Velarion Records
Free. Unsubscribe any time.

Taysha Gene Therapies, Inc. (TSHA)

Taysha Gene Therapies, Inc. filed 4 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 1 reporting owner, covering 4 transactions and 800,000 shares. None carries the SEC's AFF10B5ONE flag; all 4 name a plan in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in Taysha Gene Therapies, Inc. 4

Adoption dates in Taysha Gene Therapies, Inc. 1

Results prints in Taysha Gene Therapies, Inc. 7

Trades before a print in Taysha Gene Therapies, Inc. 0

Interval to Taysha Gene Therapies, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Taysha Gene Therapies, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on June 11, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.